Restaurant chain CAVA Group (CAVA) soared 99% in its debut on Thursday, delivering one of the best first-day performances for a $100+ million IPO in the past two years.For access to more exclusive content like this, sign up for a free trial of IPO Pro, the...read more
DICE Therapeutics, a Phase 1-ready biotech developing oral small molecule therapies for immunologic diseases, raised $204 million by offering 12 million shares at $17, the high end of the range of $15 to $17. The company offered 2 million more shares than...read more
Updated Monday, 9/13.After a wave of launches in the short holiday week, 11 IPOs are scheduled to raise over $3 billion in the week ahead.Tech consultancy Thoughtworks (TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software...read more
CAVA soars 99% in one of the best first days for a larger IPO in the past two years
Restaurant chain CAVA Group (CAVA) soared 99% in its debut on Thursday, delivering one of the best first-day performances for a $100+ million IPO in the past two years.For access to more exclusive content like this, sign up for a free trial of IPO Pro, the...read more
US IPO Weekly Recap: The Fall IPO market is in full swing with an 11 IPO week
...read more
Immunology biotech DICE Therapeutics prices upsized IPO at $17 high end
DICE Therapeutics, a Phase 1-ready biotech developing oral small molecule therapies for immunologic diseases, raised $204 million by offering 12 million shares at $17, the high end of the range of $15 to $17. The company offered 2 million more shares than...read more
US IPO Week Ahead: The Fall IPO market kicks off with an 11 IPO week
Updated Monday, 9/13.After a wave of launches in the short holiday week, 11 IPOs are scheduled to raise over $3 billion in the week ahead.Tech consultancy Thoughtworks (TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software...read more